BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6462722)

  • 1. [Relative calcitonin deficiency in calcipenic uremic osteopathy].
    Zséli J; Szücs J; Makó J; Horváth C; Holló I
    Orv Hetil; 1984 Jul; 125(30):1799-802. PubMed ID: 6462722
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of bone mineral content in patients with chronic renal failure.
    Gava A; Zorzetto M; Coghetto F; Teodori T; Marazzato G
    Rays; 1986; 11(3):67-70. PubMed ID: 3602467
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone and soft tissue damage in patients with chronic renal failure during treatment by systematic hemodialysis].
    Nenov D; Kolev Z; Vicheva S
    Urol Nefrol (Mosk); 1984; (6):53-6. PubMed ID: 6516077
    [No Abstract]   [Full Text] [Related]  

  • 4. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
    Kanis JA; Earnshaw M; Heynen G; Russell RG; Woods CG
    Calcif Tissue Res; 1977 May; 22 Suppl():147-53. PubMed ID: 912516
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutron activation analysis of a hand-a method of monitoring progressive bone disease.
    McIntosh JA; Catto GR
    Biomed Eng; 1974 Jun; 9(6):254-6 passim. PubMed ID: 4837582
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone mineral content in chronic renal failure and after renal transplantation.
    Dalén N; Alvestrand A
    Clin Nephrol; 1973; 1(6):338-46. PubMed ID: 4594997
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcitonin secretion in chronic renal patients treated with hemodialysis.
    Gozariu L; Manasia M; Paţiu IM; Vlăduţiu D; Barabas E; Spânu C; Căprioară M
    Endocrinologie; 1981; 19(4):253-6. PubMed ID: 7323650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mineral content of bone and the activity of alkaline bone phosphatase in renal bone disease treated with dialysis and after kidney transplantation].
    Koall W; Mampel E; Hintner I; Runge H
    Z Gesamte Inn Med; 1978 Jun; 33(12):403-6. PubMed ID: 356443
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of calcium oxalate deposits in bone by electron diffraction.
    Kinnett JG; Bullough PG
    Arch Pathol Lab Med; 1976 Dec; 100(12):656-8. PubMed ID: 1036678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic renal failure.
    Gutierrez LF; Kurtzman NA
    Surg Annu; 1976; 8():367-89. PubMed ID: 779071
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 12. Mineralization of bone tissue in chronic renal failure.
    Wardyn K; Dziedzic-Gocławska A; Stachowicz S; Stasiak L; Ostrowski K; Siciński A
    Acta Med Pol; 1985; 26(3-4):123-9. PubMed ID: 3837608
    [No Abstract]   [Full Text] [Related]  

  • 13. Partial-body calcium measurements by in vivo neutron activation analysis: comparisons with x-ray photodensitometry measurements of the radius.
    Harrison JE; McNeill KG; Meema HE; Fenton S; Oreopoulos DG; Sturtridge WC
    J Nucl Med; 1974 Nov; 15(11):929-34. PubMed ID: 4420966
    [No Abstract]   [Full Text] [Related]  

  • 14. [Osteopathy in long-term dialysis. Diagnostic parameters and pathogenetic factors].
    Ritz E; Krempien N; Andrassy K
    Verh Dtsch Ges Inn Med; 1972; 78():1456-9. PubMed ID: 4665582
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radiological demonstration of renal osteopathy during chronic dialysis (author's transl)].
    Banzer D; Schneider U; Hauser KP; Knoop H
    Dtsch Med Wochenschr; 1974 Jan; 99(2):48-51. PubMed ID: 4589164
    [No Abstract]   [Full Text] [Related]  

  • 16. Will bone disease still remain one of the most serious complications in dialysis patients?
    Drüeke TB
    Nephrol Dial Transplant; 1995; 10 Suppl 7():16-9. PubMed ID: 8570072
    [No Abstract]   [Full Text] [Related]  

  • 17. New bone formation and osteoid seam thickness. Appositional rate in patients undergoing renal dialysis.
    Sarnsethsiri P; Jaworski ZF; Shimizu AG; Frost HM
    Arch Pathol; 1969 Jul; 88(1):49-53. PubMed ID: 5793690
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of decreasing dialysate magnesium in patients with chronic renal failure.
    Burnell JM; Teubner E
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():191-8. PubMed ID: 1029885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amicrobic pustuloses and calcemia. Generalized pustular psoriasis, type Zumbusch, contemporary with hypocalcemia, in a patient with chronic kidney failure, under hemodialysis].
    Maleville J; Géniaux M; Aparicio M; Gauthier O; Boineau D; Mollard S
    Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):593-6. PubMed ID: 1035072
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium metabolism in patients treated with maintenance haemodialysis.
    Massry SG; Kleeman CR
    Triangle; 1971; 10(4):147-56. PubMed ID: 5148931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.